Enzyme link to breast cancer spread

Blocking a key chemical can stop breast cancer spreading to other organs, experts have discovered.







Scientists at The Institute of Cancer Research (ICR) have found, for the first time, that a particular enzyme is involved in the spread of tumour cells from the breast to other parts of the body.



If experts can successfully block the action of lysyl oxidase-like 2 (LOXL2), then treatments could be developed to stop the spread of breast cancer.



Around 47,000 new cases of breast cancer are diagnosed in the UK each year and around 12,000 die from the disease.



Recent studies have shown that the lifetime risk of the disease for women is now one in eight.



Experts blamed lifestyle factors, including obesity and drinking alcohol, for fuelling the rise.



Women are also more likely to have children later in life and fewer offspring, which influences the risk.



In the latest study, published in the journal Cancer Research, experts found that LOXL2 promotes the spread of breast cancer through the way it controls two proteins, TIMP1 and MMP9.



Other studies have shown these proteins play a role in enabling cancer to spread.



LOXL2 has also been linked to the progression of other types of the disease, including colon and oesophageal cancer.



In the latest study, scientists found that blocking LOXL2 decreased the spread of breast cancer to the lungs, liver and bone.



According to lead researcher, Dr Janine Erler, from the ICR, more than 90% of cancer deaths are because the disease has spread to other organs.



"Our study shows that inhibiting the action of LOXL2 can significantly reduce the spread of breast cancer, suggesting that drugs which block this enzyme may be effective in preventing patients' cancer from spreading," she said.



Researchers also found that high levels of LOXL2 are linked with more aggressive cancer, which results in a poor prognosis for patients.



Holly Barker, postdoctoral fellow on the study, said: "This raises the possibility that we could develop a test to measure LOXL2 levels and predict patients who will develop aggressive disease.



"This knowledge could help us tailor treatment type and intensity to individual patients."



The study was carried out using laboratory tests, meaning further research is needed to confirm the findings.



Arlene Wilkie, director of research and policy at Breast Cancer Campaign, which funded the study with the ICR and Cancer Research UK, said: "Dr Erler's results are very exciting as, although currently we can treat breast cancer that has spread, we cannot cure it.



"By using LOXL2 to predict whose cancer will spread and drugs to block the enzyme to stop this from happening, many more lives could be saved.



"This laboratory research shows great promise and we look forward to seeing how it translates into patients."



Dr Julie Sharp, senior science information manager at Cancer Research UK, said: "The team have shown that targeting the molecule LOXL2, which plays a key role in spread, could offer new approaches to tackle this problem."

PROMOTED VIDEO
Life and Style
ebookNow available in paperback
Life and Style
ebooksA superb mix of recipes serving up the freshest of local produce in a delicious range of styles
News
The 67P/CG comet as seen from the Philae lander
scienceThe most important scientific breakthroughs of 2014
Arts and Entertainment
Ian McKellen as Gandalf in The Hobbit: The Battle Of The Five Armies
film
Sport
football
Arts and Entertainment
Sarah Koenig, creator of popular podcast Serial, which is to be broadcast by the BBC
tvReview: The secret to the programme's success is that it allows its audience to play detective
News
Ruby Wax has previously written about her mental health problems in her book Sane New World
people
Latest stories from i100
Have you tried new the Independent Digital Edition apps?

ES Rentals

    Independent Dating
    and  

    By clicking 'Search' you
    are agreeing to our
    Terms of Use.

    iJobs Job Widget
    iJobs General

    Recruitment Genius: Sales Executives - OTE £60,000

    £25000 - £60000 per annum: Recruitment Genius: Are you passionate about Custom...

    Recruitment Genius: Care Workers Required - The London Borough of Bromley

    £15000 per annum: Recruitment Genius: This homecare agency is based in Beckenh...

    Recruitment Genius: Sales Executives - OTE £50,000

    £25000 - £50000 per annum: Recruitment Genius: Are you passionate about Custom...

    Recruitment Genius: Sales Executives - OTE £50,000

    £25000 - £50000 per annum: Recruitment Genius: Are you passionate about Custom...

    Day In a Page

    Homeless Veterans appeal: 'You look for someone who's an inspiration and try to be like them'

    Homeless Veterans appeal

    In 2010, Sgt Gary Jamieson stepped on an IED in Afghanistan and lost his legs and an arm. He reveals what, and who, helped him to make a remarkable recovery
    Could cannabis oil reverse the effects of cancer?

    Could cannabis oil reverse effects of cancer?

    As a film following six patients receiving the controversial treatment is released, Kate Hilpern uncovers a very slippery issue
    The Interview movie review: You can't see Seth Rogen and James Franco's Kim Jong Un assassination film, but you can read about it here

    The Interview movie review

    You can't see Seth Rogen and James Franco's Kim Jong Un assassination film, but you can read about it here
    Serial mania has propelled podcasts into the cultural mainstream

    How podcasts became mainstream

    People have consumed gripping armchair investigation Serial with a relish typically reserved for box-set binges
    Jesus Christ has become an unlikely pin-up for hipster marketing companies

    Jesus Christ has become an unlikely pin-up

    Kevin Lee Light, aka "Jesus", is the newest client of creative agency Mother while rival agency Anomaly has launched Sexy Jesus, depicting the Messiah in a series of Athena-style poses
    Rosetta space mission voted most important scientific breakthrough of 2014

    A memorable year for science – if not for mice

    The most important scientific breakthroughs of 2014
    5 best activity trackers

    Fitness technology: 5 best activity trackers

    Up the ante in your regimen and change the habits of a lifetime with this wearable tech
    Jeb Bush vs Hillary Clinton: The power dynamics of the two first families

    Jeb Bush vs Hillary Clinton

    Karen Tumulty explores the power dynamics of the two first families
    Stockholm is rivalling Silicon Valley with a hotbed of technology start-ups

    Stockholm is rivalling Silicon Valley

    The Swedish capital is home to two of the most popular video games in the world, as well as thousands of technology start-ups worth hundreds of millions of pounds – and it's all happened since 2009
    Did Japanese workers really get their symbols mixed up and display Santa on a crucifix?

    Crucified Santa: Urban myth refuses to die

    The story goes that Japanese store workers created a life-size effigy of a smiling "Father Kurisumasu" attached to a facsimile of Our Lord's final instrument of torture
    Jennifer Saunders and Kate Moss join David Walliams on set for TV adaptation of The Boy in the Dress

    The Boy in the Dress: On set with the stars

    Walliams' story about a boy who goes to school in a dress will be shown this Christmas
    La Famille Bélier is being touted as this year's Amelie - so why are many in the deaf community outraged by it?

    Deaf community outraged by La Famille Bélier

    The new film tells the story of a deaf-mute farming family and is being touted as this year's Amelie
    10 best high-end laptops

    10 best high-end laptops

    From lightweight and zippy devices to gaming beasts, we test the latest in top-spec portable computers
    Michael Carberry: ‘After such a tough time, I’m not sure I will stay in the game’

    Michael Carberry: ‘After such a tough time, I’m not sure I will stay in the game’

    The batsman has grown disillusioned after England’s Ashes debacle and allegations linking him to the Pietersen affair
    Susie Wolff: A driving force in battle for equality behind the wheel

    Susie Wolff: A driving force in battle for equality behind the wheel

    The Williams driver has had plenty of doubters, but hopes she will be judged by her ability in the cockpit